HIT earnings analysis
What we found in HIT's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
HIT's Q2 2026 operating trends improved materially from Q1: revenue held at approximately $9 million, gross margin rose to 67.8% from 51.4%, operating margin returned to 7.8% from negative 24.6%, and diluted EPS improved to $0.01 from negative $0.03. However, revenue and profitability were broadly unchanged year over year, and the company is relying on a costly and potentially dilutive financing arrangement of up to $20 million. The filing also adds a material underwriting-accuracy risk and confirms that no SEPA proceeds had been received as of the filing date.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue Held Near $9 Million
- Revenue was approximately $9 million in Q2 2026, broadly flat sequentially versus $9 million in Q1 2026 and versus $9 million in Q2 2025.
- Gross Margin Rebounded Sequentially
- Gross margin improved to 67.8% from 51.4% in Q1 2026, a 16.4 percentage-point sequential increase, but remained slightly below 67.8% in Q2 2025.
- Operations Returned to Positive Margin
- Operating margin improved to 7.8% from negative 24.6% in Q1 2026, a 32.4 percentage-point sequential improvement, and was unchanged from 7.8% in Q2 2025.
- EPS Improved Sequentially
- Diluted EPS improved to $0.01 from negative $0.03 in Q1 2026 and was unchanged from $0.01 in Q2 2025.
- Financing Provides Potential Liquidity
- The company entered into a standby equity purchase agreement providing access to up to $20 million, with prepaid advances of up to $15 million expected in tranches of $7 million, $3 million and up to $5 million.
- Capital Available for Expansion
- Management stated that net financing proceeds are intended for sales and distribution expansion, technology and product development, operations and working capital.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Underwriting Accuracy Risk Added
- The newly added risk factor states that inaccurate underwriting procedures could increase health-plan costs and pricing and cause reputational harm to the eDIYBS platform. The filing specifically identifies growth dependence on accurate underwriting and relationships with brokers, TPAs, carriers, MGUs and other agents.
- Expensive Convertible Financing
- The financing carries 8.75% annual interest, increasing to 18% upon certain defaults, and requires scheduled installment payments beginning 60 days after issuance with a 4% payment premium in some circumstances.
- Material Potential Share Dilution
- The SEPA permits issuance of up to $20 million of common stock and convertible notes, subject to an exchange cap of 13,100,378 shares, representing approximately 19.99% of outstanding Class A and Class B stock. This creates substantial potential dilution.
- Financing Proceeds Not Yet Received
- As of the filing date, the company had received $0 in proceeds and issued $0 of common shares or promissory notes under the SEPA, while the first expected $7 million tranche remained subject to specified conditions.
- Insider Selling Overhang
- The company granted its CFO a Rule 10b5-1 plan covering sales of up to 946,395 Class A shares, while the Chief Growth Officer's plan covers up to 220,000 shares.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $0.01
- Gross margin
- 67.8%
- Operating margin
- 7.8%
What they said about what is next.
The provided filing text does not include quantitative revenue or EPS guidance. The prior analysis cited full-year 2026 revenue guidance of $45 million to $50 million, but this filing excerpt does not state whether that outlook was maintained.
The filing reads about the same as the one before it.
What came before.
- 10-Q · May 14, 2026
- Health In Tech, Inc. (HIT) reported Q1 2026 results with revenue of $8.77 million, reflecting a 9.4% increase year-over-year from $8.01 million. The company reported a diluted EPS of -$0.18, compared to $0.12 in the…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing HIT makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever